Valuation check: ASXC's profit margin is -850.75%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2024
Trailing 12 months ending Jun 2024
Asensus Surgical (ASXC) currently reports a profit margin of -850.75% as of June 2024. That compares with -1124.99% in the prior-year period — up 24.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Asensus Surgical's profit margin history and peer comparisons.
Asensus Surgical's profit margin increased from -1124.99% to -850.75% — a 24.4% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Asensus Surgical's profit margin of -850.75% is lower than the Healthcare sector average of 13.89%. That is roughly 6224.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Asensus Surgical's current -850.75% should be judged against Healthcare norms (sector average: 13.89%) and against ASXC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -850.75%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Asensus Surgical, and consider following ASXC for alerts when major investors trade the stock.